Medicines and Healthcare products Regulatory Agency (MHRA)

MHRA considering ‘further action’ after metformin diabetes drugs recalled in Singapore over impurities

The Medicines and Healthcare products Regulatory Agency is considering whether to take “further action” after metformin products were recalled in Singapore over reports of contamination.…

Wholesalers ‘hoarding’ medicines could face criminal charges, says government

Wholesale dealer licence holders could face criminal charges if they hoard certain medicines that have been placed under restrictions by the government, guidance published by the Department of Health and Social Care states.…

Medicines recall drug alert issued for potentially contaminated ranitidine products

Pharmacists are being advised to stop supplying some ranitidine products after it was revealed that they may be contaminated with the impurity N-nitrosodimethylamine.…

Updated guidance says patients should receive antibiotics within four hours of pneumonia diagnosis

Antimicriobial treatment for hospital and community-acquired pneumonia should be started within four hours of diagnosis, according to updated guidance from National Institute for Health and Care Excellence and Public Health England.…

MHRA ‘assessing reports’ of respiratory illness outbreak linked to e-cigarettes in the United States

The Medicines and Healthcare products Regulatory Agency is reviewing information about a respiratory illness that has been linked to e-cigarette use in the United States.…

HRT stock update shows that supply problems are set to continue into 2020

The Department of Health and Social Care has said that six hormone replacement therapy products will be out of stock for the foreseeable future, with others facing ongoing problems well into 2020.…

Half of all safety warnings issued to drug manufacturers in India and China

The majority of warnings from European and US drug regulators are to drug manufacturing sites in India and China, raising concerns about the fragility of the global supply chain.…

Hair dye allergy test is first to be switched from prescription only

The first allergy test for hair dye to be formally reclassified from a prescription-only medicine to a general sale list medicine has been switched, the Medicines and Healthcare products Regulatory Agency has announced.…

MHRA has taken action against companies on FMD compliance

The Medicines and Healthcare Regulatory Agency has confirmed that it has taken regulatory action against a small number of companies for infringements relating to compliance with the Falsified Medicines Directive.…

It is time to enforce FMD compliance, says European Medicines Verification Organisation

The body that runs the Falsified Medicines Directive says medicines regulators in individual countries should begin enforcing its compliance.…